Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study

Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study

Abstract Introduction Mechanical heart valves (MHV) are extremely durable, but they require permanent use of anticoagulation to prevent thromboembolic events. The only approved therapeutic options are vitamin K antagonists (VKAs), such as warfarin. As a drug class, clinical management is difficult,...

Full description

Saved in:
Bibliographic Details
Main Authors: André R. Durães (Author), Yasmin de Souza Lima Bitar (Author), José Admirço L. Filho (Author), Igor S. Schonhofen (Author), Edmundo J. N. Camara (Author), Leonardo Roever (Author), Hugo E. D. P. Cardoso (Author), Kevan M. Akrami (Author)
Format: Book
Published: Adis, Springer Healthcare, 2018-10-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items